Literature DB >> 25940873

[Juvenile rheumatoid diseases: Endoprosthetic care of destroyed hip joints].

S Rehart1, M Henniger.   

Abstract

BACKGROUND: Patients with juvenile idiopathic arthritis (JIA) often suffer from involvement of the hip joints, with joint destruction and related functional limitations, making hip replacement necessary.
OBJECTIVES: To discover what special features are to be expected in patients with JIA and hip arthroplasty and what impact they have on surgical indication, choice of implant, and technique.
METHODS: Selective literature review and evaluation of our patient population.
RESULTS: Compared with osteoarthritis patients, JIA patients are on average much younger at the time of hip replacement. Owing to the onset of the disease in childhood or adolescence and the frequent glucocorticoid therapy, growth disorders or abnormal anatomical findings are common in these patients. Bone density is often reduced at an early age. The perioperative management of medication has to be planned. Special implants for patients with rheumatic diseases do not exist, but the above peculiarities of this group of patients should be considered for surgical procedure and choice of implant and material. Overall, the results of hip arthroplasty in juvenile rheumatic diseases, in terms of pain relief and functional improvement, are good. The limited life of the arthroplasty is problematic.
CONCLUSIONS: By relieving pain, improvement of the range of motion and activity level very high patient satisfaction is usually achieved by hip arthroplasty in JIA patients. In the case of involvement of the contralateral hip or the ipsilateral knee joint it may be useful to perform a simultaneous, single-stage joint replacement of both joints.

Entities:  

Mesh:

Year:  2015        PMID: 25940873     DOI: 10.1007/s00132-015-3095-y

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  31 in total

1.  [Orthopedic rheumatology].

Authors:  M Holder; M Henniger; S Rehart
Journal:  Z Orthop Unfall       Date:  2013-08-20       Impact factor: 0.923

Review 2.  Bilateral endoprosthetic total hip or knee arthroplasty.

Authors:  Joachim Pfeil; Philip Höhle; Philipp Rehbein
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

Review 3.  Has total hip arthroplasty in patients 30 years or younger improved? A systematic review.

Authors:  Muyibat A Adelani; James A Keeney; Allison Palisch; Susan A Fowler; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2013-04-06       Impact factor: 4.176

4.  The long-term outcome of hip replacement in adults with juvenile idiopathic arthritis: the influence of steroids and methotrexate.

Authors:  A Malviya; L C Walker; P Avery; S Osborne; D J Weir; H E Foster; D J Deehan
Journal:  J Bone Joint Surg Br       Date:  2011-04

5.  [Infections of the musculoskeletal system with chronic polyarthritis during a combination therapy with Methotrexate and Leflunomide].

Authors:  K S Delank; T Hansen; P Eysel; A Eckardt
Journal:  Z Orthop Ihre Grenzgeb       Date:  2002 Sep-Oct

6.  Risk factors for septic arthritis in patients with joint disease. A prospective study.

Authors:  C J Kaandorp; D Van Schaardenburg; P Krijnen; J D Habbema; M A van de Laar
Journal:  Arthritis Rheum       Date:  1995-12

7.  [Review of the results of the ARO multicenter study].

Authors:  P Arnold; B Schüle; H Schroeder-Boersch; L Jani
Journal:  Orthopade       Date:  1998-06       Impact factor: 1.087

8.  Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years.

Authors:  B Michael Wroblewski; Paul D Siney; Patricia A Fleming
Journal:  Acta Orthop       Date:  2007-04       Impact factor: 3.717

9.  [Role of orthopedic rheumatologist in the therapy of rheumatic diseases with biologics].

Authors:  S Rehart; M Henniger
Journal:  Orthopade       Date:  2014-06       Impact factor: 1.087

10.  Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate.

Authors:  R S Perhala; W S Wilke; J D Clough; A M Segal
Journal:  Arthritis Rheum       Date:  1991-02
View more
  2 in total

1.  [Therapeutic options in juvenile idiopathic arthritis : Surgical and conservative orthopedic rheumatological treatment].

Authors:  J-P Haas; M Arbogast
Journal:  Z Rheumatol       Date:  2021-04-21       Impact factor: 1.372

Review 2.  [Treatment options in juvenile idiopathic arthritis : Part 2: Orthopedics und surgery].

Authors:  M Arbogast; J-P Haas
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.